Liquid chromatographic determination of atorvastatin in bulk drug, tablets, and human plasma

被引:59
作者
Altuntas, TG [1 ]
Erk, N
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmaceut Chem, TR-06100 Ankara, Turkey
[2] Ankara Univ, Fac Pharm, Dept Analyt Chem, TR-06100 Ankara, Turkey
关键词
atorvastatin; ibuprofen; high-performance liquid chromatography; bulk drug; tablets; human plasma;
D O I
10.1081/JLC-120027087
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, specific, and accurate high performance liquid chromatographic (HPLC) method for determination of atorvastatin in bulk drug, tablets, and human plasma have been developed. Liquid chromatography was performed on a RP-Supelcosil C-18 (5 mum, 150x4.6 mm) column and the mobile phase consisted of an acetonitrile: methanol: water (45:45:10 v/v/v), and a flow rate of 1.0 mL/min. The effluent was monitored on a UV detector at 240 nm. Each analysis required no longer than 3.0 min. Quantification was achieved by the measurement of the peak area ratio of the drug to the internal standard (ibuprofen). For quantification, a calibration curve was constructed for atorvastatin concentration ranging between 0.5-86.0 mug/mL. Furthermore, the typical excipients included in the drug formulation (starch, lactose, glucose, sugar, talc, sodium chloride, titanium dioxide, and magnesium stearate) do not interfere with the selectivity of the method. Data, with respect to precision and accuracy and limits of detection, are reported and discussed. The proposed chromatographic method was successfully applied to the quantitative determination of atorvastatin in bulk drug, tablets, and spiked human plasma.
引用
收藏
页码:83 / 93
页数:11
相关论文
共 10 条
[1]   SIMULTANEOUS DETERMINATION OF TENIDAP AND ITS STABLE ISOTOPE ANALOG IN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ATMOSPHERIC-PRESSURE CHEMICAL IONIZATION TANDEM MASS-SPECTROMETRY [J].
AVERY, MJ ;
MITCHELL, DY ;
FALKNER, FC ;
FOUDA, HG .
BIOLOGICAL MASS SPECTROMETRY, 1992, 21 (07) :353-357
[2]   Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia [J].
BakkerArkema, RG ;
Davidson, MH ;
Goldstein, RJ ;
Davignon, J ;
Isaacsohn, JL ;
Weiss, SR ;
Keilson, LM ;
Brown, WV ;
Miller, VT ;
Shurzinske, LJ ;
Black, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02) :128-133
[3]   Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma [J].
Bullen, WW ;
Miller, RA ;
Hayes, RN .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 1999, 10 (01) :55-66
[4]   DETERMINATION OF METHANDROSTENOLONE AND ITS METABOLITES IN EQUINE PLASMA AND URINE BY COUPLED-COLUMN LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION AND CONFIRMATION BY TANDEM MASS-SPECTROMETRY [J].
EDLUND, PO ;
BOWERS, L ;
HENION, J .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 487 (02) :341-356
[5]  
Jemal M, 1999, RAPID COMMUN MASS SP, V13, P1003, DOI 10.1002/(SICI)1097-0231(19990615)13:11<1003::AID-RCM597>3.0.CO
[6]  
2-L
[7]   Determination of pharmaceuticals in aqueous samples using positive and negative voltage switching microbore liquid chromatography/electrospray ionization tandem mass spectrometry [J].
Miao, XS ;
Metcalfe, CD .
JOURNAL OF MASS SPECTROMETRY, 2003, 38 (01) :27-34
[8]   REDUCTION OF LDL CHOLESTEROL BY 25-PERCENT TO 60-PERCENT IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA BY ATORVASTATIN, A NEW HMG-COA REDUCTASE INHIBITOR [J].
NAWROCKI, JW ;
WEISS, SR ;
DAVIDSON, MH ;
SPRECHER, DL ;
SCHWARTZ, SL ;
LUPIEN, PJ ;
JONES, PH ;
HABER, HE ;
BLACK, DM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (05) :678-682
[9]   A four-column parallel chromatography system for isocratic or gradient LC/MS analyses [J].
Van Pelt, CK ;
Corso, TN ;
Schultz, GA ;
Lowes, S ;
Henion, J .
ANALYTICAL CHEMISTRY, 2001, 73 (03) :582-588
[10]   Texture segmentation based on MRMRF modeling [J].
Wang, L ;
Liu, J .
PATTERN RECOGNITION LETTERS, 2000, 21 (02) :189-200